Clinical Trial

Diffuse Optical Monitoring with Inhaled Nitric Oxide

Study Description

Diffuse Optical Monitoring With Inhaled Nitric Oxide

This study is a non-randomized, Phase 2 clinical trial designed to measure the cerebral blood flow (CBF) response to inhaled nitric oxide in acute ischemic stroke patients and healthy subjects. The monitoring is a 35 minute session during which cerebral hemodynamics will be monitored with both diffuse correlation spectroscopy (DCS) and transcranial doppler ultrasonography (TCD) while blood pressure, heart rate, cardiac output, respiratory rate, end oxygen saturation, and inhaled nitric oxide (NO)/nitrogen dioxide (NO2) concentration, are continuously monitored.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Nitric Oxide

Inhaled Nitric Oxide gas

Additional Information

Official Study Title

Diffuse Optical Monitoring With Inhaled Nitric Oxide

Clinical Trial ID

NCT03023449

ParticipAid ID

QeZNwe